PARADIGM ASSET MANAGEMENT CO LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 139 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 6.44 and the average weighting 0.8%.

Quarter-by-quarter ownership
PARADIGM ASSET MANAGEMENT CO LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$67,445,000
-44.0%
4,100
-51.2%
0.01%
-39.1%
Q1 2017$120,456,000
+7.5%
8,400
+3.7%
0.02%
+4.5%
Q4 2016$112,023,000
-25.3%
8,100
-2.4%
0.02%
-15.4%
Q3 2016$149,981,000
+30.6%
8,300
+3.8%
0.03%
+30.0%
Q2 2016$114,800,0008,0000.02%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$25,366,000100.00%
Artal Group S.A. 71,178,364$417,817,0007.38%
BVF INC/IL 8,394,000$49,273,0001.85%
Boothe Investment Group, Inc. 435,939$2,559,0001.49%
Campbell & CO Investment Adviser LLC 103,100$605,0000.37%
NEA Management Company, LLC 2,382,286$13,984,0000.31%
PINNACLE ASSOCIATES LTD 2,167,172$12,721,0000.24%
Eversept Partners, LP 410,593$2,410,1810.18%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$210,0000.12%
OCCUDO QUANTITATIVE STRATEGIES LP 66,299$389,0000.08%
View complete list of LEXICON PHARMACEUTICALS INC shareholders